Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: ELIQUIS (apixaban) (eliquis.com)
Eliquis presents a regulatory fortress built on a technical swamp. While the safety data is dense and high-substance, the 75% failure rate of its internal clinical navigation makes the site’s claims of being a primary resource for patients feel like hollow marketing.
Medical Devices, Pharma & Biotech Reputation: ELIQUIS (apixaban) (eliquis.com)
The site strongly matches the Pharma & Biotech category, characterized by extensive mandatory safety disclosures and clinical indications. The presence of Boxed WARNINGS and specific dosage strengths (2.5 mg and 5 mg) confirms its role as a regulated prescription medicine platform.
“The score is driven primarily by the total collapse of Semantic Coherence and Identity & Authority. While Information Density is high for safety content, the technical failure of the sub-pages (404 errors) and the presence of unverified review counts (Trust Theatre) create a high BS-profile despite the brand's legitimate pharmaceutical status.”